Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: JOHN WHITE who wrote (1178)	6/28/1998 5:40:00 PM
From: thomas a. burke	Respond to of 4650

John, I like the idea of cross ownership with these two companies. They appear to have a very symbiotic relationship. Have the flat panel displays for the cancer detection systems actually been completed? This company is now fully reporting, with a large stake in cutting edge medical technology(through Biomoda), and hopefully they will maintain the rights to manufacture flat panel displays for cancer detection even if Biomoda sells this technology. Oh, I almost forgot, possible revenue from ADOTs own business, which could generate high revenues over time. Looking for a good week. Tom B.

To: JOHN WHITE who wrote (1178)	6/28/1998 7:38:00 PM
From: Brad	Read Replies (1) \| Respond to of 4650

Here are some interesting points from the 10SB filed 6-23-98, of which many people may be unaware... 1) The price of the flat panel remote billboard is approximately $1,000,000, as opposed to the $ 14,000,000 price on the existing market. 2) There have been approximately 100 to 125 inquiries about this product from major outdoor advertising agencies for their high visibility billboards. 3) For stadium use the displays will also achieve full motion. The ability to transmit for daytime bright and clear viewing is one of the benefits of the flat panel display. 4) For the 3-Month Period Ending March 31, 1998, ADOT showed a Positive $0.0158 EPS. This was based on Weighted Ave. Shares Outstanding of 11,157,596. (Long-term contracts are accounted for using the percentage of completion method, with revenues recognized in proportion that costs incurred bear to estimated total costs at completion.) 5) Total Liabilities were only $34,277 with Total Assets of $1,515,747 of which $739,493 was CASH ! Just some food for thought. Best wishes, Brad PS. John, I didn't find any numbers relating to the number of shares Biomoda might have of ADOT. I found only the numbers relating to ADOT's ownership of Biomoda shares.